LIFESTYLE MEDICINE • DEPRESCRIBING • METABOLIC PERFORMANCE

Deprescribing, done properly.

Doctor-led medication reviews and safe step-down plans — built around your physiology, risks, and goals.

Private consultations in Sutton Coldfield (supporting Birmingham, Solihull, Lichfield, Tamworth, Walsall and surrounding areas). CQC-registered clinic appointments via Sutton Medical Consulting.

No reckless stopping. Clear monitoring points. Follow-up options if needed.
Clinical appointments are provided by CQC-registered
Sutton Medical Consulting

Common reasons people book a deprescribing review

• Side effects you were told to tolerate

Your health improved — your prescription list didn’t

• You want a safe exit plan — not guesswork

You’ve got multiple prescribers, and the plan has drifted

WHAT DESPRESCRBING MEANS

Deprescribing is the careful reduction or stopping of medications that may no longer be helping — or may now be causing more harm than benefit.

It’s not anti-medicine. It’s medicine done properly: the same clinical reasoning used to start a drug, applied again later when your physiology, weight, blood pressure, symptoms, or risk profile has changed.

A lot of people accumulate prescriptions during stressful years — illness, low sleep, weight gain, injury, menopause, a difficult season — and then never get a clean re-assessment once things improve.

My job is to review the whole picture, then build a safe step-down plan you can actually follow.

If you’re unsure whether a medication still makes sense, that’s usually the right moment for a review.

PATHWAYS

Choose your review.

Start with the medication you’re most unsure about. Not sure? Start with Medication list review — we’ll map the whole list.

  • Dr Dan Reardon and GLP-1

    GLP-1 exit strategy

    Exit planning, appetite rebound, and long-term weight maintenance.

  • Dr Dan Reardon and SSRIs

    SSRI review

    Review, risks, and a careful taper plan when appropriate.

  • Dr Dan Reardon and PPIs

    PPI step-down

    Reflux step-down, rebound symptoms, and prevention strategies.

  • Dr Dan Reardon and Statins

    Statin review

    Primary prevention decisions: benefits, trade-offs, and alternatives.

  • Dr Dan Reardon and Blood Pressure

    Blood pressure meds step-down

    Step-down after weight loss/fitness gains — with monitoring points.

  • Dr Dan Reardon and Polypharmacy

    Medication list review

    Whole-list review: interactions, duplication, and a staged plan.

A structured review → a stepwise plan → clear monitoring points and follow-up options.

Deprescribing = reviewing whether a medication is still needed, still helping, and still worth the trade-offs.

Sometimes the outcome is continue (with reassurance).

Sometimes it’s adjust, replace, reduce, or stop — with monitoring.

WHAT THIS IS

Not “stopping meds”. A structured clinical decision.

Nothing is stopped abruptly; decisions are personalised and safety-led.

WHO IT’S FOR

If you recognise yourself in any of these, you’re in the right place.

  • On a GLP-1

    and thinking “I can’t stay on this forever.”

  • Statin doubts

    Muscle pain, fatigue, or uncertainty about benefit.

  • SSRI plateau

    You’re stable, but don’t want to be stuck indefinitely.

  • PPIs long-term

    Reflux control, but dependency and rebound worries.

  • Blood pressure meds after lifestyle change

    Weight down, fitness up — meds unchanged.

  • Multiple meds + low clarity:

    Polypharmacy, interactions, and “what is each one for?”

WHAT YOU GET

A clear, medically defensible plan — not internet advice.

Medication clarity

What each drug is doing, what it’s costing, what alternatives exist.

A taper/adjustment roadmap

Stepwise plan + rebound symptom planning where relevant.

A physiological strategy

sleep, nutrition, training, stress, labs — aimed at reducing the need for medication over time.

HOW I WORK

Clinical judgement + metabolic intelligence

A structured review that turns medication questions into a safe, stepwise plan — with physiology doing the heavy lifting.

The Metabolic Intelligence Review
Doctor-led medication review + metabolic strategy

01History & goals

What you’re taking — and why

What you want to change

What you can realistically sustain

02 — Medication & risk review

Benefit vs side effects

Interactions / duplication

Is the original indication still present?

03 — Physiology plan

Nutrition, training, sleep, stress

Metabolic markers & targeted labs (if needed)

The levers that reduce reliance over time

04 — Stepwise change

Taper/adjust roadmap (when appropriate)

Rebound symptoms planned for

Follow-ups to course-correct safely

You leave with: a written plan + what to monitor + when we review.

Principle: assess risk first, act in steps, and monitor what matters.

That’s emergency medicine thinking — applied to long-term metabolic health.

Clinical appointments are provided by CQC-registered Sutton Medical Consulting

BOUNDARIES

Safe, evidence-led, and not ideological.

FAQ

The practical questions — answered clearly.

  • It can be, when it’s planned, stepwise, and tailored to your risks. The aim is to reduce medication that’s no longer helping while monitoring symptoms and key markers.

  • If you want, you’ll leave with a clear written summary of the rationale and plan to share with your GP or prescribing clinician.

  • It depends on the medication, dose, and your response. Some changes are straightforward; others are stepped over weeks to months with monitoring points built in.

  • That’s anticipated. We agree in advance what’s likely to rebound and what we’ll do if it does—pause, slow the pace, adjust, or reconsider.

  • No. If you’re acutely unwell or worried about urgent symptoms, use the appropriate urgent care route.

  • No. The goal is the right medication list—sometimes that means continuing what’s genuinely beneficial.

  • A current medication list (including OTC/supplements) and any recent blood tests or home readings you have.

RELATED READING

If you want the detail

Coming off Wegovy or Ozempic: what to expect

SSRI withdrawal vs relapse

PPI rebound explained

Statins: when stopping is appropriate (and when it isn’t)